Phase 3 N=402 Randomized Treatment

Maintaining Nonsmoking: Older Smokers - 1

Tobacco Use Disorder

Bottom Line

View on ClinicalTrials.gov: NCT00086385 ↗

Enrolled (actual)

402

Serious AEs

3.2%

Results posted

Oct 2013

Primary outcome: Primary: Participants Abstinent From Cigarettes — 31; 35; 39; 45 participants

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Nicotine polacrilex, Bupropion (Drug)
Age: Adult, Older Adult · 50+ yrs
Sex: All
Sponsor: University of California, San Francisco
Primary completion: Mar 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Participants Abstinent From Cigarettes	31; 35; 39; 45	—

Summary

The purpose of this study was to examine pharmacological and psychological interventions for smokers over 50.

Eligibility Criteria

smokers of at least 10 cigarettes per day

Inclusion Criteria

MULTIPLE

Exclusion Criteria

MULTIPLE

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00086385). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.